1 year 0.1
Extreme 0.1
0.1
3 years 0.1
Extreme 0.1
0.1
5 years 0.1
Extreme 0.1
0.1
10 years 0.1
Extreme 0.1
0.1
Manager TitleAgeSince
Chief Executive Officer 62 2023-01-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer 55 2017-07-31
Director TitleAgeSince
Director/Board Member 61 -
Chairman 78 -
Chairman 63 2023-01-16
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 6.31M
+1.97%+2.03%+21.92%+0.83% 195B
+5.87%+5.27%-21.76%+26.78% 151B
+2.17%+0.89%-2.59%-16.42% 140B
+4.83%+2.06%-56.73%-15.69% 67.09B
+2.59%+3.95%+22.89%+3.15% 54.34B
+0.03%+2.19%-25.48%-31.00% 44.63B
+0.31%+1.30%+8.30%+43.25% 37.24B
-2.02%-3.91%+7.67%+9.53% 36.91B
+4.24%+4.66%-18.42%-2.34% 30.24B
Average +2.00%+2.47%-7.13%+2.01% 75.59B
Weighted average by Cap. +2.78%+3.44%-4.03%+2.02%

Financials

2024 2025
Net sales 10.51M 1.09M 953K 875K 816K 1.55M 104M 1.57M 4.08M 50.97M 4.09M 4M 177M 16.65M 1.73M 1.51M 1.39M 1.29M 2.45M 164M 2.49M 6.47M 80.73M 6.48M 6.34M 281M
Net income -20.18M -2.09M -1.83M -1.68M -1.57M -2.97M -199M -3.01M -7.84M -97.84M -7.85M -7.68M -340M -17.52M -1.82M -1.59M -1.46M -1.36M -2.58M -173M -2.62M -6.81M -84.96M -6.82M -6.67M -295M
Net Debt - -
Logo Phase Holographic Imaging PHI AB
Phase Holographic Imaging PHI AB (PHI) is a Sweden-based company active in the field of medical technology. It develops and markets time-lapse cytometers for clinical applications. The products use holographic microscopy technology, with image sensors capturing light information from objects, and computer processing the information to create visual image. It is also engaged in the development of related software. Its method allows to view and measure living cell over time, without disturbing or destroying it. PHI collaborates with cancer- and stem cell researchers, among others. The Company’s product portfolio includes HoloMonitor M3, a bench-top time-lapse cytometer, and HoloMonitor M4, allowing cell analysis in the cultivation incubator.
Employees
15
  1. Stock Market
  2. Stocks
  3. PHIX.F Stock